With a strong international presence, we are poised for further expansion
ECONOMY & POLICY

With a strong international presence, we are poised for further expansion

EPC company Varindera Constructions (VCL) has completed 31 construction projects in the past 10 years with 20 ongoing projects in India and overseas as in March 2024. Varinder Kumar Garg, Chairman, shares factors behind the company’s stellar performance in its residential, commercial, metro, railway and institution projects and the material magnitude of the Hasimara Air Force Station project, which plays a key role in deployment and operations of Rafale jets in India, as well as his perspective on the latest technologies, sustainability, skill shortage and the company’s international expansion plans. Excerpts: 
 
What factors would you attribute to your performance?
Since inception, VCL has been steadfast in its commitment to nation-building. Our performance over the last decade aligns perfectly with the vision of an Atmanirbhar Bharat. As India embarks on its Amrit Kaal, poised to become the third-largest economy, we are dedicated to playing a significant role in shaping the new Bharat...

To read the full article Click Here

EPC company Varindera Constructions (VCL) has completed 31 construction projects in the past 10 years with 20 ongoing projects in India and overseas as in March 2024. Varinder Kumar Garg, Chairman, shares factors behind the company’s stellar performance in its residential, commercial, metro, railway and institution projects and the material magnitude of the Hasimara Air Force Station project, which plays a key role in deployment and operations of Rafale jets in India, as well as his perspective on the latest technologies, sustainability, skill shortage and the company’s international expansion plans. Excerpts:  What factors would you attribute to your performance?Since inception, VCL has been steadfast in its commitment to nation-building. Our performance over the last decade aligns perfectly with the vision of an Atmanirbhar Bharat. As India embarks on its Amrit Kaal, poised to become the third-largest economy, we are dedicated to playing a significant role in shaping the new Bharat...To read the full article Click Here

Next Story
Infrastructure Urban

Mahindra Logistics Launches New Warehouse in Phaltan

Mahindra Logistics Ltd., one of India’s largest integrated logistics solutions providers, has inaugurated a new state-of-the-art warehousing facility in Phaltan, Maharashtra. This development enhances the company’s presence in one of India’s most rapidly growing industrial corridors.Spanning over 300,000 square feet, the newly operational facility has been developed as a dedicated logistics centre for Cummins India, a leading power solutions provider. The warehouse aims to streamline Cummins India’s nationwide operations by consolidating products from multiple sources into a centralise..

Next Story
Infrastructure Urban

Greaves Electric Mobility Names Vikas Singh as MD

Greaves Electric Mobility Limited (GEML), the electric mobility arm of Greaves Cotton Limited, has appointed Mr Vikas Singh as its new Managing Director, effective 2nd June 2025. In his new role, Mr Singh will lead the company’s next phase of growth, with all key members of the current management team reporting directly to him.Mr Singh brings with him extensive leadership experience from some of India’s most competitive consumer-facing industries. Known for his ability to steer companies through regulated environments, he has demonstrated a strong capacity to drive organisational transform..

Next Story
Infrastructure Urban

OneSource, Xbrane Partner for Global Biosimilar Supply

OneSource Specialty Pharma Limited, a multi-modality specialty pharmaceutical contract development and manufacturing organisation (CDMO), has announced a strategic manufacturing partnership with Sweden-based Xbrane Biopharma AB (Nasdaq: XBRANE), a leading biotechnology firm. The collaboration will focus on the commercial production of Xbrane’s biosimilar portfolio.Xbrane’s biosimilar pipeline targets an estimated EUR 23 billion in annual peak sales of the reference biologics. Its lead candidate, Ximluci—a biosimilar of ranibizumab—has already received market authorisation in Europe and..

Advertisement

Advertisement

Subscribe to Our Newsletter

Get daily newsletters around different themes from Construction world.

STAY CONNECTED

Advertisement

Advertisement

Advertisement

Advertisement

Talk to us?